These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8400243

  • 1. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.
    Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM.
    Blood; 1993 Sep 15; 82(6):1929-36. PubMed ID: 8400243
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
    Delage R, Soiffer RJ, Dear K, Ritz J.
    Blood; 1991 Nov 15; 78(10):2759-67. PubMed ID: 1824268
    [Abstract] [Full Text] [Related]

  • 3. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB, Tavares Rde C, Hassan R, Zalcberg I, Tabak DG, Seuánez HN.
    Leuk Res; 2002 Feb 15; 26(2):129-41. PubMed ID: 11755463
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

  • 5. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R.
    Proc Natl Acad Sci U S A; 1990 Jan 01; 87(2):563-7. PubMed ID: 2405384
    [Abstract] [Full Text] [Related]

  • 6. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F, van Rhee F, Goldman JM, Cross NC.
    Blood; 1996 May 15; 87(10):4473-8. PubMed ID: 8639810
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 8. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 9. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S, Galili N, Sklar JL, Donlon TA, Blume KG, Cleary ML.
    Leukemia; 1990 Aug 15; 4(8):541-7. PubMed ID: 2201832
    [Abstract] [Full Text] [Related]

  • 10. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.
    Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P.
    Blood; 1995 May 01; 85(9):2632-8. PubMed ID: 7727789
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1147-52. PubMed ID: 8971386
    [Abstract] [Full Text] [Related]

  • 12. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 13. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
    Ni H, Nitta M, Komatsu H, Kojima S, Suzuki S, Harada S, Tsuboi K, Banno S, Wakita A, Yazaki M, Ren L, Kato T, Ueda R.
    Cancer Lett; 1998 Feb 27; 124(2):173-80. PubMed ID: 9500207
    [Abstract] [Full Text] [Related]

  • 14. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
    Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC.
    Blood; 1996 Feb 15; 87(4):1549-55. PubMed ID: 8608246
    [Abstract] [Full Text] [Related]

  • 15. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.
    Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y.
    Blood; 1993 Feb 15; 81(4):1089-93. PubMed ID: 8427990
    [Abstract] [Full Text] [Related]

  • 16. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
    Preudhomme C, Révillion F, Merlat A, Hornez L, Roumier C, Duflos-Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P.
    Leukemia; 1999 Jun 15; 13(6):957-64. PubMed ID: 10360386
    [Abstract] [Full Text] [Related]

  • 17. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
    Arnold R, Janssen JW, Heinze B, Bunjes D, Hertenstein B, Wiesneth M, Kubanek B, Heimpel H, Bartram CR.
    Leukemia; 1993 May 15; 7(5):747-51. PubMed ID: 8483329
    [Abstract] [Full Text] [Related]

  • 18. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW.
    Ann Hematol; 2000 Aug 15; 79(8):424-31. PubMed ID: 10985361
    [Abstract] [Full Text] [Related]

  • 19. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
    Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S.
    Br J Haematol; 1992 Dec 15; 82(4):708-14. PubMed ID: 1482658
    [Abstract] [Full Text] [Related]

  • 20. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H.
    Leukemia; 1995 Aug 15; 9(8):1353-60. PubMed ID: 7643624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.